share_log

CEO Addresses Shareholders: Reflect Scientific's Competitive Position Remains Strong, Showcasing New Milestones and Promising Future

CEO Addresses Shareholders: Reflect Scientific's Competitive Position Remains Strong, Showcasing New Milestones and Promising Future

首席執行官向股東致辭:Reflect Scientific 的競爭地位仍然強勁,展示了新的里程碑和
GlobeNewswire ·  2023/06/13 20:00

OREM, Utah, June 13, 2023 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (Symbol: RSCF), a leading provider of cutting-edge freezing and chilling technologies, is pleased to report on its continued success and market dominance. Today, the CEO, Mr. Kim Boyce, addressed shareholders to highlight the company's achievements and outline the promising prospects.

猶他州奧雷姆,2023年6月13日(Global Newswire)--Reflect Science Inc.(代碼:RSCF),一家領先的尖端冷凍和冷凍技術供應商,高興地報告了其持續的成功和市場主導地位。今天,首席執行官Mr.Kim·博伊斯向股東發表講話,強調了公司的成就,並概述了前景。

Reflect Scientific's unwavering commitment to technological advancement has enabled the company to meet market demands with unparalleled products, delivering exceptional performance. As a testament to this, we recently secured a significant supply agreement with a prominent international biopharma company. With over 30 locations worldwide, this agreement underscores the reliability and outstanding performance of our unique line of liquid nitrogen freezing equipment, already in use at several of their facilities.

Reflect Science對技術進步的堅定不移的承諾使公司能夠以無與倫比的產品滿足市場需求,提供卓越的性能。作為證明,我們最近與一家著名的國際生物製藥公司達成了一項重要的供應協定。這項協定在全球擁有30多個地點,突顯了我們獨特的液氮冷凍設備系列的可靠性和出色的性能,這些設備已經在他們的幾個設施中使用。

In addition, we are thrilled to witness the continued adoption of our technology by our existing customer base. Our customers are upgrading their equipment to leverage the advanced features of our newest model ultra-low temperature freezers. Moreover, we have received numerous requests for price quotations for freezers from other esteemed biopharma companies, spanning processing and storage applications.

此外,我們很高興看到我們現有的客戶群繼續採用我們的技術。我們的客戶正在升級他們的設備,以利用我們最新型號的超低溫冷凍機的先進功能。此外,我們還收到了許多來自其他受人尊敬的生物製藥公司的冰櫃報價請求,涉及加工和存儲應用。

Reflect Scientific has been featured in more than 50 articles published in reputable biotech, pharmaceutical, and related journals to ensure widespread exposure. These publications emphasize the remarkable advantages our patented line of liquid nitrogen freezers offers. Furthermore, we are actively pursuing expanded representation through a prominent distributor with an extensive presence in biopharma and associated industries. This strategic initiative would provide access to thousands of customer locations, including scientists and research laboratories across more than 100 countries. Our success extends beyond the biomedical field. Our CBD/THC chilling technology has outperformed competitors in various commercial applications, delivering exceptional yields and purity.

Reflect Science已被髮表在知名生物技術、製藥和相關期刊上的50多篇文章中,以確保廣泛曝光。這些出版物強調了我們的專利液氮冷凍機系列提供的顯著優勢。此外,我們正通過一家在生物製藥和相關行業擁有廣泛業務的知名分銷商積極尋求擴大代表權。這一戰略計劃將提供與數千個客戶地點的聯繫,包括100多個國家的科學家和研究實驗室。我們的成功超越了生物醫學領域。我們的CBD/THC冷凍技術在各種商業應用中的表現優於競爭對手,提供了卓越的產量和純度。

Reflect Scientific is pleased to announce new opportunities on the horizon. We have recently partnered with a major aircraft manufacturer to explore the application of our unique chilling technology. We have signed a non-disclosure agreement (NDA) to facilitate further development. Additionally, we are engaged in a contract with a prominent customer in the chemical industry, paving the way for broader applications of our freezing technology in bulk material preservation.

Reflect Science很高興地宣佈即將出現新的機會。我們最近與一家大型飛機制造商合作,探索我們獨特的冷卻技術的應用。我們已經簽署了保密協定(NDA),以促進進一步的發展。此外,我們還與化工行業的一家知名客戶簽訂了合同,為我們的冷凍技術在散裝材料保存中的更廣泛應用鋪平了道路。

In response to market demands, we recently unveiled our latest innovation—the patented Mini Blast freezer. This groundbreaking product has generated substantial interest, enabling customers to conduct research and development of new drugs on a smaller scale before scaling up to production using our proven B-90 Blast/Thaw freezing technology.

為了回應市場需求,我們最近推出了我們的最新創新-專利迷你鼓風冷凍機。這種突破性的產品引起了極大的興趣,使客戶能夠在使用我們成熟的B-90 BLAST/融化冷凍技術擴大生產之前,以較小的規模進行新藥的研究和開發。

Reflect Scientific is proud to announce the granting of numerous new patents in recent months. These patents will be showcased in the coming months, demonstrating our ongoing commitment to innovation. Notably, one of the patents involves using cryogens such as liquid nitrogen or liquid air in household, institutional, and industrial applications for cooling, refrigeration, and freezing. This groundbreaking invention also has the potential to revolutionize Reefer transportation, offering an entirely green application with zero emissions and the avoidance of hydrofluorocarbons, a potent greenhouse gas (HFCs).

Reflect Science自豪地宣佈,近幾個月來授予了許多新專利。這些專利將在未來幾個月展示,表明我們對創新的持續承諾。值得注意的是,其中一項專利涉及在家庭、機構和工業應用中使用液氮或液態空氣等冷凍劑進行冷卻、製冷和冷凍。這項突破性的發明還有可能給冷藏運輸帶來革命性的變化,提供一種完全綠色的應用,零排放,避免氫氟碳化物,一種強有力的溫室氣體(HFCs)。

In summary, Reflect Scientific remains highly optimistic about our prospects. Our unique and highly acclaimed products have gained significant market acceptance, our robust technology platform continues to unveil new opportunities, and we remain dedicated to investing in product innovation. Stay tuned for forthcoming announcements regarding recent order volumes.

總而言之,Reflect Science對我們的前景保持高度樂觀。我們獨特且廣受好評的產品已經獲得了市場的廣泛認可,我們強大的技術平臺不斷推出新的機會,我們將繼續致力於投資於產品創新。敬請關注即將發佈的有關最近訂單量的公告。

Finally, we are pleased to inform our valued shareholders that Reflect Scientific is debt-free, further solidifying our strong financial position.

最後,我們很高興地通知我們尊貴的股東,這反映出科學公司沒有債務,進一步鞏固了我們強大的財務狀況。

Regards
Mr. Kim Boyce, CEO

問候
首席執行官Mr.Kim·博伊斯

About Reflect Scientific, Inc.
Reflect Scientific is a leading provider of state-of-the-art freezing and chilling technologies. With a commitment to innovation and superior performance, Reflect Scientific's cutting-edge products serve diverse industries, including biotechnology, pharmaceuticals, chemicals, and more. By leveraging advanced cryogenic solutions, Reflect Scientific empowers customers worldwide to achieve optimal results in preserving and processing vital materials. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn .

Reflect Science公司簡介
Reflect Science是最先進的冷凍和冷凍技術的領先提供商。憑藉對創新和卓越性能的承諾,Reflect Science的尖端產品服務於不同的行業,包括生物技術、製藥、化工等。通過利用先進的低溫解決方案,Reflect Science使世界各地的客戶能夠在保存和處理重要材料方面實現最佳結果。有關更多資訊,請訪問ReflectScience fic.com。在Twitter@ReflectSci和LinkedIn上看到我們。

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."

前瞻性陳述
本新聞稿包含符合修訂後的1933年證券法第27A節和修訂後的1934年證券交易法第21E節的前瞻性陳述。前瞻性陳述不是對未來業績或結果的保證,也不一定準確地說明實現業績或結果的時間或方式。前瞻性陳述以作出陳述時可獲得的資訊為基礎,涉及已知和未知的風險、不確定因素和其他因素,這些風險、不確定性和其他因素可能會導致我們的結果、活動水準、業績或成就與本新聞稿中前瞻性陳述明示或暗示的資訊大不相同。考慮本新聞稿時,應參考場外交易市場集團LLC以“RSCF”為交易代碼提交的公司檔案中所包含的披露內容,以及該公司在該檔案中引用幷包含在證券交易委員會埃德加檔案檔案中“披露”標題下的相關檔案,包括在此類檔案中標識為“前瞻性陳述”的檔案。

CONTACT: Contact Investor Relations 801-607-1039 investor_relations@reflectscientific.com
聯繫人:投資者關系部801-607-1039

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論